Call Us Contact Us
+44 1494 818 000     Online Enquiry
Lines open
Monday to Thursday
08:30 to 18:00
Friday
08:30 to 17:30
Pharmaceutical | Medical Devices | Scientific | Consumer Healthcare | Dental | Animal Health | FMCG | Executive
         
Latest Jobs

London
19 June 2013 13:28



North East
19 June 2013 12:49



Hertfordshire
19 June 2013 12:48


Have you registered?
Once you register you can see additional job details, save jobs, track your applications and manage e-lert preferences.

Register now
Testimonials
I'd like to say a huge thank you to all the staff at Zenopa from initial contact to job offer. In particular I'd like to thank you to my contact for their professionalism.
Steven, 2011

Kimerbly-Clark reports third-quarter financial results

11 November 2009 00:00 in Pharmacy / Pharmacist News


Kimberly-Clark has published its financial results for the third quarter of 2009, reporting a decrease in net sales of 1.7 per cent to $4.9 billion (2.9 billion pounds).

This, it states is due to the effect of weaker foreign currency exchange rates.

A growth in organic sales was driven by higher net selling prices and the firm revealed that overall, these volumes were even with those recorded during the same period of 2008.

Sales increased by around 18 per cent for Kimberly-Clark's global healthcare business and about three per cent for its operations in developing and emerging markets.

"All-in-all, we continue to execute our business plans well and I'm really pleased that bottom-line results in the third quarter are spurring a significant increase in our outlook for the year," explained chairman and chief executive officer Thomas Falk.

At the beginning of September, Kimberly-Clark announced that it had recruited Kim Underhill as its new vice-president, following the departure of former employee Giles Turrell.

Other news stories from 11/11/2009

Recent news

Read more in the Zenopa News Archive

How this news is generated

Story collated for Zenopa by the Adfero News Agency



             
© Copyright 2013 Zenopa Ltd